Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Impact of Triazole Therapeutic Drug Monitoring Availability and Timing.

McCreary EK, Bayless M, Van AP, Lepak AJ, Wiebe DA, Schulz LT, Andes DR.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e01245-19. doi: 10.1128/AAC.01245-19. Print 2019 Oct.

PMID:
31332058
2.

IT'S TIME TO STOP PRESCRIBING ERGOCALCIFEROL.

Binkley NC, Wiebe DA.

Endocr Pract. 2018 Dec;24(12):1099-1102. doi: 10.4158/EP-2018-0415. Epub 2018 Oct 5. No abstract available.

PMID:
30289309
3.

Development of a sensitive LC/MS/MS method for vitamin D metabolites: 1,25 Dihydroxyvitamin D2&3 measurement using a novel derivatization agent.

Hedman CJ, Wiebe DA, Dey S, Plath J, Kemnitz JW, Ziegler TE.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Mar 15;953-954:62-7. doi: 10.1016/j.jchromb.2014.01.045. Epub 2014 Feb 4.

4.

Health perceptions in patients who undergo screening and workup for prostate cancer.

Katz DA, Jarrard DF, McHorney CA, Hillis SL, Wiebe DA, Fryback DG.

Urology. 2007 Feb;69(2):215-20.

5.

HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays.

Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK.

Clin Chem. 2006 Jun;52(6):1120-6. Epub 2006 Mar 30.

6.

Postprandial lipoprotein changes in patients taking antiretroviral therapy for HIV infection.

Stein JH, Merwood MA, Bellehumeur JB, McBride PE, Wiebe DA, Sosman JM.

Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):399-405. Epub 2004 Dec 2.

PMID:
15576636
7.

Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver.

Turchin A, Wiebe DA, Seely EW, Graham T, Longo W, Soiffer R.

Bone Marrow Transplant. 2005 Jan;35(1):85-9.

PMID:
15531904
8.

Inaccuracy of lipid measurements with the portable Cholestech L.D.X analyzer in patients with hypercholesterolemia.

Stein JH, Carlsson CM, Papcke-Benson K, Einerson JA, McBride PE, Wiebe DA.

Clin Chem. 2002 Feb;48(2):284-90.

9.

Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease.

Chou EJ, Keevil JG, Aeschlimann S, Wiebe DA, Folts JD, Stein JH.

Am J Cardiol. 2001 Sep 1;88(5):553-5. No abstract available.

PMID:
11524068
10.

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction.

Stein JH, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, Sosman JM.

Circulation. 2001 Jul 17;104(3):257-62.

PMID:
11457741
11.
12.

Assessment of interlaboratory performance in external proficiency testing programs with a direct HDL-cholesterol assay.

Rifai N, Cole TG, Iannotti E, Law T, Macke M, Miller R, Dowd D, Wiebe DA.

Clin Chem. 1998 Jul;44(7):1452-8.

13.

Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.

Allen TM, Sidney J, del Guercio MF, Glickman RL, Lensmeyer GL, Wiebe DA, DeMars R, Pauza CD, Johnson RP, Sette A, Watkins DI.

J Immunol. 1998 Jun 15;160(12):6062-71.

16.

Optimized method for determination of gabapentin in serum by high-performance liquid chromatography.

Lensmeyer GL, Kempf T, Gidal BE, Wiebe DA.

Ther Drug Monit. 1995 Jun;17(3):251-8.

PMID:
7624921
17.
18.

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment.

Love RR, Wiebe DA, Feyzi JM, Newcomb PA, Chappell RJ.

J Natl Cancer Inst. 1994 Oct 19;86(20):1534-9.

PMID:
7932809
19.

Lipid testing for the year 2000 and beyond.

Wiebe DA.

Atherosclerosis. 1994 Aug;108 Suppl:S181-9.

PMID:
7802724
20.

Cholesterol--a model system to relate medical needs with analytical performance.

Wiebe DA, Westgard JO.

Clin Chem. 1993 Jul;39(7):1504-12; discussion 1512-3. Review.

21.

Correlations between scores on the Wechsler Intelligence Scale for Children-III and the General Purpose Abbreviated Battery of the Stanford-Binet IV.

Carvajal HH, Hayes JE, Lackey KL, Rathke ML, Wiebe DA, Weaver KA.

Psychol Rep. 1993 Jun;72(3 Pt 2):1167-70.

PMID:
8337322
22.
23.

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women.

Love RR, Wiebe DA, Newcomb PA, Cameron L, Leventhal H, Jordan VC, Feyzi J, DeMets DL.

Ann Intern Med. 1991 Dec 1;115(11):860-4.

PMID:
1952472
24.
25.
26.

Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro.

Schultz JC, Lensmeyer GL, Wendal TD, Shahidi NT, Wiebe DA, Carlson IH.

Biochem Pharmacol. 1991 Sep 12;42(7):1403-10.

PMID:
1834063
27.
28.

Concentrations of cyclosporin A and its metabolites in human tissues postmortem.

Lensmeyer GL, Wiebe DA, Carlson IH, Subramanian R.

J Anal Toxicol. 1991 May-Jun;15(3):110-5.

PMID:
1943052
29.
30.

Effect of freezing on cholesterol in individual sera.

Miller WG, Levine JB, Santulli M, Flom KJ, Greenberg N, Kessner A, O'Neal WR, Wiebe DA, Adiletto C.

Clin Chem. 1991 Apr;37(4):584-5. No abstract available.

31.

Rapid and specific cyclosporine assay for the Du Pont aca discrete clinical analyzer performed directly on whole blood.

Hansen JB, Lau HP, Janes CJ, Miller WK, Wiebe DA.

J Clin Lab Anal. 1991;5(3):187-92.

PMID:
2061742
32.

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

Love RR, Newcomb PA, Wiebe DA, Surawicz TS, Jordan VC, Carbone PP, DeMets DL.

J Natl Cancer Inst. 1990 Aug 15;82(16):1327-32.

PMID:
2199681
33.

Fatal intravenous injection of monooctanoin.

Hejka AG, Poquette M, Wiebe DA, Huntington RW 3rd.

Am J Forensic Med Pathol. 1990 Jun;11(2):165-70.

PMID:
2343846
35.
36.

Effects of interleukin-2 (IL-2) on human plasma lipid, lipoprotein, and C-reactive protein.

Rosenzweig IB, Wiebe DA, Hank JA, Albers JJ, Adolphson JL, Borden E, Shrago ES, Sondel PM.

Biotherapy. 1990;2(3):193-8.

PMID:
1698421
38.

Testing cholesterol accuracy. Performance of several common laboratory instruments.

Koch DD, Hassemer DJ, Wiebe DA, Laessig RH.

JAMA. 1988 Nov 4;260(17):2552-7.

PMID:
3172430
39.

Deposition of nine metabolites of cyclosporine in human tissues, bile, urine, and whole blood.

Lensmeyer GL, Wiebe DA, Carlson IH.

Transplant Proc. 1988 Apr;20(2 Suppl 2):614-22. No abstract available.

PMID:
3363658
40.

Ophthalmic observations in lecithin cholesterol acyltransferase deficiency.

Vrabec MP, Shapiro MB, Koller E, Wiebe DA, Henricks J, Albers JJ.

Arch Ophthalmol. 1988 Feb;106(2):225-9.

PMID:
3341979
43.

Plasma lipoprotein changes in humans induced by beta-interferon.

Rosenzweig IB, Wiebe DA, Borden EC, Storer B, Shrago ES.

Atherosclerosis. 1987 Oct;67(2-3):261-7.

PMID:
3079540
44.

Effects of recombinant interferon-alpha 2 treatment upon lipid concentrations and lipoprotein composition.

Massaro ER, Borden EC, Hawkins MJ, Wiebe DA, Shrago E.

J Interferon Res. 1986 Dec;6(6):655-62.

PMID:
3572087
46.

International survey of apolipoproteins A1 and B measurements (1983-1984).

Cooper GR, Smith SJ, Wiebe DA, Kuchmak M, Hannon WH.

Clin Chem. 1985 Feb;31(2):223-8.

47.
48.

Coronary artery disease mortality in relatives of hypertriglyceridemic school children: the Muscatine study.

Schrott HG, Clarke WR, Abrahams P, Wiebe DA, Lauer RM.

Circulation. 1982 Feb;65(2):300-5.

PMID:
7053887
49.

Triglyceride and cholesterol concentrations in whole serum and in serum lipoproteins in Reye syndrome.

Chaves-Carballo E, Carter GA, Wiebe DA.

Pediatrics. 1979 Nov;64(5):592-7.

PMID:
226924
50.

Increased coronary mortality in relatives of hypercholesterolemic school children: the Muscatine study.

Schrott HG, Clarke WR, Wiebe DA, Connor WE, Lauer RM.

Circulation. 1979 Feb;59(2):320-6.

PMID:
758999

Supplemental Content

Loading ...
Support Center